{"id":"beclomethasone-hfa","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Oropharyngeal candidiasis"},{"rate":"1-5","effect":"Tremor"},{"rate":"5-10","effect":"Headache"},{"rate":"1-5","effect":"Dysphonia"},{"rate":"5-10","effect":"Throat irritation"}]},"_chembl":{"chemblId":"CHEMBL1586","moleculeType":"Small molecule","molecularWeight":"408.92"},"_dailymed":{"setId":"cada897a-264e-450d-ae00-36e7fe747080","title":"QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA) AEROSOL, METERED [TEVA RESPIRATORY, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Beclomethasone binds to glucocorticoid receptors in airway tissues, leading to decreased production of inflammatory cytokines, reduced recruitment of eosinophils and other immune cells, and decreased mucus production. This anti-inflammatory action reduces airway obstruction and hyperresponsiveness in asthma and COPD.","oneSentence":"Beclomethasone is a corticosteroid that reduces inflammation in the airways by suppressing immune cell activity and inflammatory mediator release.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:43:10.751Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma maintenance therapy"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT06272370","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care","status":"COMPLETED","sponsor":"DARTNet Institute","startDate":"2024-02-01","conditions":"Asthma, Bronchial Diseases, Respiratory Tract Infections","enrollment":103},{"nctId":"NCT05898984","phase":"PHASE1","title":"Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-04-24","conditions":"Asthma","enrollment":69},{"nctId":"NCT00476268","phase":"PHASE3","title":"Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2004-02","conditions":"Asthma","enrollment":824},{"nctId":"NCT03453112","phase":"PHASE3","title":"Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2017-10-09","conditions":"Asthma","enrollment":494},{"nctId":"NCT01615874","phase":"PHASE2","title":"Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT03084718","phase":"PHASE2","title":"An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2017-07-28","conditions":"Asthma","enrollment":610},{"nctId":"NCT01024608","phase":"PHASE3","title":"Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-12-31","conditions":"Seasonal Allergic Rhinitis, Hay Fever","enrollment":340},{"nctId":"NCT00988247","phase":"PHASE3","title":"Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-10-31","conditions":"Rhinitis, Allergic, Perennial","enrollment":529},{"nctId":"NCT00250341","phase":"PHASE4","title":"Non-invasive Measures of Distal Lung Disease in Asthmatics","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2005-09-30","conditions":"Asthma","enrollment":34},{"nctId":"NCT00071552","phase":"PHASE4","title":"Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2004-01-31","conditions":"Asthma","enrollment":49},{"nctId":"NCT00094016","phase":"PHASE3","title":"Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2004-10-31","conditions":"Asthma","enrollment":440},{"nctId":"NCT02139644","phase":"PHASE3","title":"Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-06","conditions":"Asthma","enrollment":787},{"nctId":"NCT02031640","phase":"PHASE3","title":"A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-12","conditions":"Asthma","enrollment":1113},{"nctId":"NCT02040779","phase":"PHASE3","title":"A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-12-26","conditions":"Persistent Asthma","enrollment":273},{"nctId":"NCT02040766","phase":"PHASE3","title":"A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-12","conditions":"Asthma","enrollment":628},{"nctId":"NCT02513160","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-09-30","conditions":"Persistent Asthma","enrollment":713},{"nctId":"NCT01343745","phase":"PHASE2","title":"Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2008-02","conditions":"Mild Persistent Asthma","enrollment":18},{"nctId":"NCT04051710","phase":"PHASE3","title":"Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH","status":"COMPLETED","sponsor":"Aurobindo Pharma Ltd","startDate":"2019-03-12","conditions":"Bronchial Asthma","enrollment":1550},{"nctId":"NCT00557180","phase":"","title":"Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications","status":"COMPLETED","sponsor":"National Jewish Health","startDate":"2007-10","conditions":"Asthma, Obesity","enrollment":33},{"nctId":"NCT01848769","phase":"PHASE2","title":"Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-09","conditions":"Asthma","enrollment":20},{"nctId":"NCT03562949","phase":"PHASE3","title":"A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol","status":"TERMINATED","sponsor":"Amneal Ireland Limited","startDate":"2018-12-06","conditions":"Asthma","enrollment":761},{"nctId":"NCT01894048","phase":"PHASE4","title":"Targeted Small Airways Therapy in Persistent Asthma","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2013-10-28","conditions":"Asthma","enrollment":26},{"nctId":"NCT03834012","phase":"PHASE3","title":"Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma","status":"WITHDRAWN","sponsor":"Adamis Pharmaceuticals Corporation","startDate":"2019-02","conditions":"Asthma","enrollment":""},{"nctId":"NCT03835871","phase":"PHASE3","title":"Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma","status":"WITHDRAWN","sponsor":"Adamis Pharmaceuticals Corporation","startDate":"2019-02","conditions":"Asthma","enrollment":""},{"nctId":"NCT00829257","phase":"PHASE4","title":"Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2009-01","conditions":"Asthma","enrollment":15},{"nctId":"NCT00921921","phase":"PHASE4","title":"Does Extra-fine Hydrofluoroalkane-beclomethasone Dipropionate (HFA-BDP) Suppress Small Airways Inflammation in Chronic Obstructive Pulmonary Disease (COPD)?","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2009-06","conditions":"COPD","enrollment":16},{"nctId":"NCT00394329","phase":"PHASE3","title":"(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2006-11","conditions":"Asthma","enrollment":288},{"nctId":"NCT03503994","phase":"NA","title":"Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2001-07-27","conditions":"Bronchopulmonary Dysplasia","enrollment":41},{"nctId":"NCT00862394","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-02","conditions":"Asthma","enrollment":783},{"nctId":"NCT00826748","phase":"PHASE4","title":"Effect of Inhaled Steroids on Gene Expression in the Lungs - 2","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2010-11","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":24},{"nctId":"NCT00200967","phase":"PHASE3","title":"Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2004-12","conditions":"Asthma","enrollment":87},{"nctId":"NCT00936793","phase":"PHASE1","title":"Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2009-07-06","conditions":"HIV, Asthma","enrollment":53},{"nctId":"NCT00528723","phase":"PHASE3","title":"Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2007-11","conditions":"Bronchial Asthma","enrollment":180},{"nctId":"NCT01370031","phase":"PHASE2","title":"Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2011-04","conditions":"Asthma","enrollment":16},{"nctId":"NCT00862264","phase":"PHASE3","title":"Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2004-08","conditions":"Asthma","enrollment":286},{"nctId":"NCT00868023","phase":"PHASE2","title":"Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-02","conditions":"Asthma","enrollment":69},{"nctId":"NCT00238082","phase":"NA","title":"The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease","status":"TERMINATED","sponsor":"National Jewish Health","startDate":"1999-11","conditions":"COPD","enrollment":20},{"nctId":"NCT01584492","phase":"PHASE2","title":"Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2011-12","conditions":"Asthma","enrollment":59},{"nctId":"NCT00659048","phase":"PHASE3","title":"Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-12","conditions":"Rhinitis, Allergic, Perennial","enrollment":106},{"nctId":"NCT01741285","phase":"PHASE4","title":"Effects of QVAR in Smokers With Asthma","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2013-04","conditions":"Asthma","enrollment":40},{"nctId":"NCT00532584","phase":"PHASE4","title":"Effect of Steroids on Gene Expression in the Healthy Smokers Lungs","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2011-02","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":""},{"nctId":"NCT01006655","phase":"PHASE2","title":"The Effect of HFA - Beclomethasone Dipropionate Qvar on Bronchial Hyperreactivity in Preschool Children","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2009-03","conditions":"Asthma, Bronchial Hyperresponsiveness","enrollment":21},{"nctId":"NCT01307319","phase":"PHASE3","title":"Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2011-03","conditions":"Seasonal Allergic Rhinitis, SAR","enrollment":715},{"nctId":"NCT02113072","phase":"PHASE3","title":"Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.","status":"COMPLETED","sponsor":"Universidade Federal de Pernambuco","startDate":"2014-04","conditions":"Respiratory Tract Diseases, Wheezing","enrollment":60},{"nctId":"NCT01620099","phase":"PHASE4","title":"Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study","status":"COMPLETED","sponsor":"Università degli Studi di Ferrara","startDate":"2011-11","conditions":"Asthma","enrollment":60},{"nctId":"NCT01287351","phase":"","title":"Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2004-01","conditions":"Asthma","enrollment":82903},{"nctId":"NCT00495157","phase":"PHASE3","title":"Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2007-06","conditions":"Asthma","enrollment":342},{"nctId":"NCT01141439","phase":"","title":"Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2001-01","conditions":"Asthma","enrollment":815377},{"nctId":"NCT01729351","phase":"","title":"Qvar Therapy in Smoking Asthmatics","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2011-11","conditions":"Asthma, Smoking","enrollment":7195},{"nctId":"NCT01400217","phase":"","title":"Qvar Versus Clenil, a General Practice Research Database Study","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"1991-01","conditions":"Asthma","enrollment":56985},{"nctId":"NCT01697722","phase":"","title":"Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination Therapy","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"1991-01","conditions":"Asthma","enrollment":815377},{"nctId":"NCT01133626","phase":"PHASE3","title":"Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-06","conditions":"Perennial Allergic Rhinitis","enrollment":107},{"nctId":"NCT01134705","phase":"PHASE3","title":"Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-05","conditions":"Rhinitis, Allergic, Perennial","enrollment":474},{"nctId":"NCT00854360","phase":"PHASE2","title":"Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-03","conditions":"Seasonal Allergic Rhinitis, Hayfever","enrollment":487},{"nctId":"NCT01537692","phase":"PHASE1","title":"Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-03","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT01141452","phase":"","title":"Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2001-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":815377},{"nctId":"NCT01255579","phase":"PHASE4","title":"Effects on Small Airways of Two Long-term Extrafine Treatments in Asthma","status":"COMPLETED","sponsor":"Università degli Studi di Brescia","startDate":"2007-07","conditions":"Bronchial Asthma","enrollment":10},{"nctId":"NCT00254956","phase":"PHASE3","title":"Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-01","conditions":"Respiratory Tract Diseases, Respiratory Hypersensitivity, Asthma","enrollment":1568},{"nctId":"NCT00402207","phase":"NA","title":"The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2005-08","conditions":"Asthma","enrollment":33}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["QVAR"],"phase":"marketed","status":"active","brandName":"beclomethasone HFA","genericName":"beclomethasone HFA","companyName":"Milton S. Hershey Medical Center","companyId":"milton-s-hershey-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Beclomethasone is a corticosteroid that reduces inflammation in the airways by suppressing immune cell activity and inflammatory mediator release. Used for Asthma maintenance therapy, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}